- Global Pharma News & Resources

Global Hyperpigmentation Treatment Market expected to reach US$ 11.84 billion by 2033

The global hyperpigmentation treatment market is expected to be worth $4.78 billion in 2023, with a compound annual growth rate (CAGR) of 7.4% projected from 2023 to 2033. Skin hyperpigmentation results from a slight decrease in melanin synthesis. Laser treatment, cosmeceuticals, and chemical peels can all be used to treat hyperpigmentation disorders. The global hyperpigmentation market is also being influenced by an increase in the incidence of melasma, as well as a thorough knowledge of hyperpigmentation treatment modalities.

The popularity of the Hyperpigmentation Treatment Market is increasing due to a steady stream of new product releases and asset utilization by significant prominent stakeholders in research and development. Furthermore, rising demand for outpatient and microsurgical processes is anticipated to lead to lucrative opportunities in the Hyperpigmentation Treatment Market in the coming years. Furthermore, the global economy for hyperpigmentation Disorders Treatment may suffer as a result of insufficient favorable reimbursement and high demand for cosmetic procedures.

Request Sample Copy of Report@

Dermabrasion practices, such as enhanced us and of lasers in the diagnosis of pigmentation disorders and rising cosmetics spending globally, are expected to drive market growth. Researchers have been investigating how nanotechnology can improve active substance delivery and ingestion to the skin, in addition to the efficacy of specific therapeutic drugs. Because of its ability to improve the properties of skincare products in general, nanotechnology has emerged as a feasible addition to beauty products.

Key Takeaways from the Market Study

  • Hyperpigmentation Treatment market is predicted to exceed an impressive valuation of US$ 4.78 billion in 2023.
  • Sales increased significantly from 2018 to 2022, with a CAGR of 7.1%.
  • In 2021, Asia Pacific will account for approximately 36% of the global hyperpigmentation disorder services market.
  • The crystal microdermabrasion device segment in the United States is projected to expand at a CAGR of 9% during the forecast period.
  • The global Hyperpigmentation Treatment market is anticipated to be worth US$ 11.84 billion by 2033.

“Offering laser therapy and phototherapy to help the industry grow over the next few years. Moreover, automakers that treat hyperpigmentation illnesses have lucrative deals as a result of technological advances in cosmeceuticals and a boost in the use of pharmaceuticals in skincare.” says FMI’s analyst.

Ask an Analyst@

Key Market Players

Key players in the Hyperpigmentation Treatment market are Episciences, Vivier Pharma, La Roche-Posay, Pierre Fabre Dermo Cosmetique, Bayer, Alvogen, Allergen, Obagi Medical Products, SkinCeuticals International, and L’Oréal Paris.

  • In September 2022, L’Oréal acquired Skinbetter Science, a practitioner U.S.-based skincare brand backed by cutting-edge dermatological science that combines internally developed efficacious additives with glamorous sensorial textures.
  • Obagi Medical Products introduced the Obagi Nu-Derm® Systems in October 2022, which help to convert skin by addressing hyperpigmentation and improving visible signs of aging.

Key Segments Profiled in the Hyperpigmentation Treatment Market Industry Survey

By Type:

  • Pharmacological Therapy
  • Laser Treatment
  • Chemical Peels and Bleach
  • Microdermabrasion
  • Skin Grafting or Plastic Surgery

By Application:

  • Skin Clinics
  • Drug and Cosmetic Stores
  • Hypermarkets and Supermarkets

Buy Now@

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.


Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
Browse All Reports:

Editor Details

Last Updated: 01-Feb-2023